These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28677069)

  • 1. High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
    Higashi K; Ueda Y; Shimasaki M; Ishigaki Y; Nakamura Y; Oguchi M; Takegami T; Watanabe N
    Ann Nucl Med; 2017 Oct; 31(8):590-595. PubMed ID: 28677069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
    Higashi K; Ueda Y; Ikeda R; Kodama Y; Guo J; Matsunari I; Oguchi M; Tonami H; Katsuda S; Yamamoto I
    Nucl Med Commun; 2004 Jan; 25(1):19-27. PubMed ID: 15061261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
    Shimizu K; Hirami Y; Saisho S; Yukawa T; Maeda A; Yasuda K; Nakata M
    Ann Thorac Surg; 2012 Feb; 93(2):398-403. PubMed ID: 22206958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
    Liu Y; Wu N; Bi GC; Zhang DS; Zheng R; Liang Y; Zhang WJ; Li XM; Fang Y
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):263-9. PubMed ID: 27087372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features.
    Higashi K; Ueda Y; Ayabe K; Sakurai A; Seki H; Nambu Y; Oguchi M; Shikata H; Taki S; Tonami H; Katsuda S; Yamamoto I
    Nucl Med Commun; 2000 Aug; 21(8):707-14. PubMed ID: 11039452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
    Guo J; Higashi K; Yokota H; Nagao Y; Ueda Y; Kodama Y; Oguchi M; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2004 Aug; 45(8):1334-9. PubMed ID: 15299058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
    Zhang L; Higashi K; Ishigaki Y; Ueda Y; Sakuma T; Takegami T; Oguchi M; Xu K; Ohta Y; Nishida H; Tonami H
    Ann Nucl Med; 2010 Aug; 24(7):533-40. PubMed ID: 20607627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
    Guo J; Higashi K; Ueda Y; Oguchi M; Takegami T; Toga H; Sakuma T; Yokota H; Katsuda S; Tonami H; Yamamoto I
    J Nucl Med; 2006 Mar; 47(3):419-25. PubMed ID: 16513610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-A and its isoform VEGF₁₂₁ mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study.
    Guo J; Higashi K; Ueda Y; Ishigaki Y; Sakuma T; Oguchi M; Takegami T; Ohta Y; Zhang L; Xu K; Nishida H; Tonami H
    Ann Nucl Med; 2011 Jan; 25(1):29-36. PubMed ID: 20941554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
    Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
    Vesselle H; Salskov A; Turcotte E; Wiens L; Schmidt R; Jordan CD; Vallières E; Wood DE
    J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma.
    Huang P; Zhao X; Xiao W; Dong Y; Hu G
    Oncotarget; 2017 Jun; 8(24):39618-39626. PubMed ID: 28489603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
    Ohtsuka T; Nomori H; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
    Cancer; 2006 Nov; 107(10):2468-73. PubMed ID: 17036361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
    Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.
    Duan XY; Wang W; Li M; Li Y; Guo YM
    Braz J Med Biol Res; 2015 Mar; 48(3):267-72. PubMed ID: 25651460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
    Kwon W; Howard BA; Herndon JE; Patz EF
    J Thorac Oncol; 2015 Jun; 10(6):897-902. PubMed ID: 25811445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
    Duan Y; Yu LJ; Lu PO; Wang WZ
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.